-
Impinj to make IPO
SEATTLE — A company that makes tracking technology for retailers and drug companies is making an initial public offering.
Seattle-based Impinj, which makes ultra-high-frequency radio-frequency identification tags, made the announcement Thursday, saying it had filed a registration statement with the Securities and Exchange Commission relating to a proposed IPO.
Impinj’s tags, which are cheaper and smaller than regular RFID tags, are used by retailers to track inventory and by drug companies to keep counterfeit drugs out of the supply chain.
-
Valeant issues letter to Cephalon stockholders
MISSISSAUGA, Ontario — Valeant Pharmaceuticals International is taking its case directly to Cephalon’s shareholders in its effort to acquire the Frazer, Pa.-based drug maker.
In a letter to the shareholders Thursday, Valeant said its $73-per-share offer, totaling $5.7 billion, was a 29% premium over the 30-day stock price of Cephalon, noting that the price had declined over the last five years and that the average stock price in the month before the offer was $57, which Wall Street analysts didn’t expect to rise above $60.